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Deletion of Vhl in β cells or the pancreas impairs glucose homeostasis in mice. (A) Recombination of the Vhl allele was assayed by PCR in islets, 
cerebral cortex (cortex), and hypothalami (hyp) from WT and KO mice for βVhlKO and PVhlKO mice. Positive and negative PCR controls for dele-
tion were performed using DNA from Vhl-null cells, Vhl control (cont) cells, WT cells, and without addition of DNA. Arrows indicate the deleted allele. 
(B and C) Hif-1α staining using chromogenic detection (left and middle panels) in islets from control, βVhlKO, and PVhlKO mice and combined 
chromogenic/immunofluorescence staining (right panels) co-localizing Hif-1α and insulin in islets from βVhlKO and PVhlKO mice. (D and E) Fed 
blood glucose levels in 12-week-old female control, βVhlKO, and PVhlKO mice. n = 8. (F and G) Blood glucose after an intraperitoneal injection 
(2 g/kg body weight) of glucose in 12-week-old female control, βVhlKO, and PVhlKO mice. n = 8 for null alleles; n = 24 for control animals. (H and I) Fed 
plasma insulin levels in 12-week-old female control, βVhlKO, and PVhlKO mice. n = 8. *P < 0.05, **P < 0.01, ***P < 0.001 compared with control.
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Defective GSIS in mice lacking Vhl in β cells or the pancreas. (A) Plasma insulin levels before and after an intraperitoneal injection of glucose 
(3 g/kg body weight) in 12-week-old female control (open squares) and PVhlKO (filled squares) mice. n = 7–9 per genotype. (B and C) Insulin 
secretion from isolated control (open squares) and βVhlKO islets (closed squares) in response to perifusion with 2 and 20 mmol/l glucose 
and 500 nmol/l phorbol ester (PMA). n = 3. (D) Insulin secretion from isolated control and PVhlKO islets in static cultures in response to 2 and 
20 mmol/l glucose. n = 5. (E) Insulin secretion from isolated control and βVhlKO islets in static cultures in response to 2 and 20 mmol/l glucose, 
10 mmol/l α-ketoisocaproic acid (αKIC), and 25 mmol/l potassium chloride (KCl). n = 8. **P < 0.01.
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Deletion of Vhl in β cells or in the pancreas does not alter β cell mass, pro-


































Dependence of abnormal glucose homeostasis on upregulation of Hif-1α and phenotype of βHif1aKO mice. (A) Western blot for Hif-1α and 
tubulin loading control in Min6 cells transfected with activated Hif-1α mutant. α-tubulin was resolved on a 10% gel, and Hif-1α was analyzed on 
a separate 6% gel after equal amounts of the same cell lysate were loaded. Blots are typical of 2 independent experiments. (B) Insulin secretion 
from Min6 cells transfected with activated Hif-1α mutant or empty vector in response to 2 and 30 mmol/l glucose. n = 5. (C) Blood glucose after 
an intraperitoneal injection (2 g/kg body weight) of glucose in 4- to 6-month-old male control (open squares) and βVhlHif1aKO (filled squares) 
mice. n = 8. (D) Blood glucose after an intraperitoneal injection (2 g/kg body weight) of glucose in 4- to 6-month-old male control (open squares) 
and βHif1aKO (filled squares) mice. n = 8. (E) Insulin secretion from isolated control, βHif1aKO, and βVhlHif1aKO islets from 4- to 6-month-old 
male mice in static cultures in response to 2 and 20 mmol/l glucose. n = 8. *P < 0.05, **P < 0.01 compared with control.
research article
	 The	Journal	of	Clinical	Investigation      http://www.jci.org      Volume 119      Number 1      January 2009  129
Figure 4
Abnormal expression of 
glucose-sensing appara-
tus and glycolytic genes 
in βVhlKO and PVhlKO 
mice. (A and B) Expres-
sion of Glut1, Glut2, and 
Gck  mRNA in βVhlKO 
and PVhlKO islets rela-
tive to control islets. n = 5. 
(C) Glut1 immunostaining 
in control, βVhlKO, and 
PVhlKO islets. Represen-
tative images are shown. 
Scale bars: 150 μm. (D and 
E) Glut2 (green) and insu-
lin (red) staining in control, 
βVhlKO, and PVhlKO islets. 
Representative images are 
shown. Scale bars: 100 μm. 
(F) Western blotting for 
Hif-1α, Glut1, Glut2, and 
α-tubulin (loading con-
trol) in islets isolated from 
PVhlKO mice. Glut1, Glut2, 
and α-tubulin were resolved 
on a 10% gel, and blots 
were probed and stripped 
for each of the 3 antibod-
ies. Hif-1α was analyzed 
on a separate 6% gel with 
an equal amount of the 
same cell lysate loaded. 
Representative blots are 
shown and are typical of 
2 independent experi-
ments. (G) Expression of 
Glut1 and Glut2 mRNA in 
Min6 cells transfected with 
activated HIF1α mutant 
relative to empty vector–
transfected control cells. 
n = 3. (H and I) Expres-
sion of Gapdh, Aldola, 
Pfk, and Pdk1 mRNA in iso-
lated βVhlKO and PVhlKO 
islets relative to control 
islets. n = 5. *P < 0.05, 
**P < 0.01, ***P < 0.001 
compared with control.
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in  response  to glucose,  indicating  that activation of HIF-1α 
perturbs GSIS (Figure 3B).
Rescue of defective glucose homeostasis in βVhlKO mice by concomitant 

































Alteration in expression of key components of the glucose-sensing appa-





































Glucose uptake and metabolism is impaired in β cells lacking Vhl, 
but mitochondrial function is preserved. (A) Continuous monitoring of 
2-NBDG uptake (18 nmol/l added at the time points indicated by verti-
cal arrows) into control and βVhlKO β cells incubated in 2.5 mmol/l 
D-glucose. (B and C) Rate of uptake of 2-NBDG into β cells from con-
trol, βVhlKO, and PVhlKO mice. n = 8 groups of β cells from 3 ani-
mals of each genotype. *P < 0.05, **P < 0.01 compared with control. 
(D–G) NADH and FAD++ autofluorescence was monitored by confocal 
microscopy for control (D and F), βVhlKO (E), and PVhlKO (G) β cells 
at the indicated glucose concentrations. Results are expressed as 
a percentage of basal values ± SEM for 8 groups of β cells from 3 
animals of each genotype. (H and I) Ca2+ signals in response to indi-
cated glucose concentrations and tolbutamide (200 μmol/l) in control, 
βVhlKO, and PVhlKO β cells. Recordings were made from 50 cells of 
each genotype from 2 animals of each genotype. (J and K) Ca2+ sig-
nals in response to methyl succinate (10 mmol/l) in control, βVhlKO, 
and PVhlKO β cells. Recordings were made from 50 cells of each 
genotype from 2 animals of each genotype.
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